Figure 2.
Stratification into the pre-specified cohorts. Blast clearance is defined as ≤5% blasts in the BM after the start of 1L therapy and before the end of 1L therapy. rwCR/CRh is defined as ≤5% blasts in the BM with at minimum partial count recovery (platelet count >50 × 109/L and absolute neutrophil count >0.5 × 109/L) within the period ± 14 days of the blast assessment. Abbreviations: 1L, first-line; BM, bone marrow; rwCR/CRh, real-world complete response/complete response with partial hematologic recovery.